Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Jackson

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.
Life Science Alliance|January 27, 2019
Mitochondrial stress response triggered by defects in protein synthesis quality controlUwe Richter, Kah Ying Ng, Fumi Suomi, et al.
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
International Journal of Cancer|October 2, 2020
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based studySophie Pilleron, Hadrien Charvat, Marzieh Araghi, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX studySara Lonardi, Iwona Ługowska, Anne O'Donnell, et al.
Journal of Neuro-Oncology|June 16, 2025
Automated feature learning and survival prognostication in grade 4 glioma using supervised machine learning modelsYuncong Mao, Linda Tang, Melanie Alfonzo Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2018
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line <i>RAS</i> Wild-Type Metastatic Colorectal CancerAndrew G Hill, Michael P Findlay, Matthew E Burge, et al.
NPJ Digital Medicine|September 29, 2024
Blending space and time to talk about cancer in extended realityTamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
The Lancet. Gastroenterology & Hepatology|May 21, 2019
Changes in colorectal cancer incidence in seven high-income countries: a population-based studyMarzieh Araghi, Isabelle Soerjomataram, Aude Bardot, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.
Life Science Alliance|January 27, 2019
Mitochondrial stress response triggered by defects in protein synthesis quality controlUwe Richter, Kah Ying Ng, Fumi Suomi, et al.
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
International Journal of Cancer|October 2, 2020
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based studySophie Pilleron, Hadrien Charvat, Marzieh Araghi, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX studySara Lonardi, Iwona Ługowska, Anne O'Donnell, et al.
Journal of Neuro-Oncology|June 16, 2025
Automated feature learning and survival prognostication in grade 4 glioma using supervised machine learning modelsYuncong Mao, Linda Tang, Melanie Alfonzo Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2018
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line <i>RAS</i> Wild-Type Metastatic Colorectal CancerAndrew G Hill, Michael P Findlay, Matthew E Burge, et al.
NPJ Digital Medicine|September 29, 2024
Blending space and time to talk about cancer in extended realityTamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
The Lancet. Gastroenterology & Hepatology|May 21, 2019
Changes in colorectal cancer incidence in seven high-income countries: a population-based studyMarzieh Araghi, Isabelle Soerjomataram, Aude Bardot, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Pageof 21